Novel application of guanfu base A and guanfu base G
A technology of Guanfu A and Guanfuheptin, which is applied in the field of preparation of drugs for inhibiting the activity of drug-metabolizing enzymes, and can solve the problems of no literature reports on specific inhibitory effects
Active Publication Date: 2012-08-22
CHINA PHARM UNIV +1
View PDF0 Cites 2 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0004] In the drug screening process, specific CYP2D6 inhibitors can be used in the prediction research of drug interactions, and the diterpenoid alkaloids of Guanbaifuzhong involved in the present invention are mainly composed of Guanfu A and its hydrochloric acid or sulfate, Guanfu There is no literature report on the specific inhibitory effect of fuheptin and its hydrochloric acid or sulfate on CYP2D6
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0124] Take Guanfu A hydrochloride, sucrose, cornstarch, and magnesium stearate in a ratio of 1:16:5:0.3 by weight and make a capsule according to a conventional method.
Embodiment 2
[0126] Get 10 g of heptanine sulfate, sucrose, cornstarch, and magnesium stearate in a ratio of 1:16:5:0.3 by weight, and make tablets according to a conventional method.
Embodiment 3
[0128] Take Guanfu A hydrochloride 1g, make intravenous injection according to the conventional process.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more PUM
Login to view more
Abstract
The invention provides the application of norditerpenoid alkaloids which are guanfu base A and guanfu base G in Korean mondshood roots in the aspect of suppressing the activity of drug metabolizing enzymes. By the guanfu base A and the guanfu base G, the activity of CYP2D6 can be directly suppressed, the metabolism of drugs (substrates) is retarded, and the drug effect is reinforced; and moreover, the guanfu base A and the guanfu base G have no influence to the activity of other metabolizing enzymes.
Description
technical field [0001] The invention relates to a new application of diterpene alkaloids, in particular to the application of Guanfu A and Guanfuheptin in the preparation of drugs for inhibiting the activity of drug-metabolizing enzymes. Background technique [0002] Guanbaifu is the root tuber of Aconitum coreanum (Levl,) Rapaics, a traditional Chinese medicine. It is one of the common Chinese medicines. It is mainly used for heartache and blood stagnation. Its chemical composition is mainly related to Guanfu base G (GFG), Guanfu base A (GFA), etc., both of which are diterpenoid alkaloids. Among them, Guanfu A is a new type of safe and effective broad-spectrum antiarrhythmic drug discovered for the first time. [0003] Cytochrome P450 (CYP) is a superfamily enzyme system composed of isozymes encoded by the superfamily of genes related to structure and function, although the content of CYP2D6 accounts for only 2% of all CYP isozymes in the liver. 5%, but the drugs involved...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/439A61P43/00
Inventor 孙建国王广基彭英董秀华吴慧尚丽丽刘静涵杨春华王国栋刘可俞广为胡天娇
Owner CHINA PHARM UNIV
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap